<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<oembed>
  <author_name>a-radion-note</author_name>
  <author_url>https://blog.hatena.ne.jp/a-radion-note/</author_url>
  <blog_title>放射線治療医　海野しおんの雑記帳</blog_title>
  <blog_url>https://uminoshion.hatenablog.com/</blog_url>
  <categories>
    <anon>食道がん</anon>
    <anon>食道胃接合部がん</anon>
    <anon>術前化学放射線療法</anon>
  </categories>
  <description>Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial.Eyck BM, van Lanschot JJB, Hulshof MCCM, et al. J Clin Oncol. 2021 Jun 20;39(18):1995-2004. doi: 10.1200/JCO.20.03614. Epub 2021 Apr 23. PMID: 33891478. 【概要】・食道がん/食道胃接合部がんに対するC…</description>
  <height>190</height>
  <html>&lt;iframe src=&quot;https://hatenablog-parts.com/embed?url=https%3A%2F%2Fuminoshion.hatenablog.com%2Fentry%2F2025%2F08%2F11%2F121718&quot; title=&quot;【食道がん】食道がん/食道胃接合部がんに対する術前化学放射線療法【CROSS試験：第III相試験、10年成績】 - 放射線治療医　海野しおんの雑記帳&quot; class=&quot;embed-card embed-blogcard&quot; scrolling=&quot;no&quot; frameborder=&quot;0&quot; style=&quot;display: block; width: 100%; height: 190px; max-width: 500px; margin: 10px 0px;&quot;&gt;&lt;/iframe&gt;</html>
  <image_url></image_url>
  <provider_name>Hatena Blog</provider_name>
  <provider_url>https://hatena.blog</provider_url>
  <published>2025-08-11 12:17:18</published>
  <title>【食道がん】食道がん/食道胃接合部がんに対する術前化学放射線療法【CROSS試験：第III相試験、10年成績】</title>
  <type>rich</type>
  <url>https://uminoshion.hatenablog.com/entry/2025/08/11/121718</url>
  <version>1.0</version>
  <width>100%</width>
</oembed>
